117 related articles for article (PubMed ID: 24566798)
1. Of hammers and screws: renin-angiotensin-aldosterone system inhibition to prevent atrial fibrillation in patients with hypertension.
Kirchhof P; Fabritz L
Eur Heart J; 2014 May; 35(18):1169-71. PubMed ID: 24566798
[No Abstract] [Full Text] [Related]
2. [Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
Geller JC
MMW Fortschr Med; 2003 Nov; 145(47):38-41. PubMed ID: 14725032
[TBL] [Abstract][Full Text] [Related]
3. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Boos CJ; Lip GY
J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
[No Abstract] [Full Text] [Related]
4. Summaries for patients. Effect of antihypertensive drugs on risk for atrial fibrillation.
Ann Intern Med; 2010 Jan; 152(2):I-16. PubMed ID: 20083810
[No Abstract] [Full Text] [Related]
5. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
6. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system.
Le Heuzey JY; Marijon E; Chachoua K; Waintraub X; Lepillier A; Otmani A; Lavergne T; Pornin M
Arch Cardiovasc Dis; 2008; 101(11-12):787-91. PubMed ID: 19059574
[TBL] [Abstract][Full Text] [Related]
8. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II inhibition and prevention of atrial fibrillation and stroke.
Bourassa MG
J Am Coll Cardiol; 2005 Mar; 45(5):720-1. PubMed ID: 15734616
[No Abstract] [Full Text] [Related]
10. Atrial fibrillation and blood pressure.
Harv Heart Lett; 2009 Jun; 19(10):6. PubMed ID: 19681208
[No Abstract] [Full Text] [Related]
11. Global systolic load, left ventricular hypertrophy, and atrial fibrillation.
Bang CN; Greve AM; Wachtell K; Kober L
Am Heart J; 2012 Oct; 164(4):e13. PubMed ID: 23067925
[No Abstract] [Full Text] [Related]
12. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
[No Abstract] [Full Text] [Related]
13. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy regression and atrial fibrillation incidence.
Hyman MH
JAMA; 2007 Jan; 297(1):40; author reply 40-1. PubMed ID: 17200471
[No Abstract] [Full Text] [Related]
15. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K
Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232
[TBL] [Abstract][Full Text] [Related]
16. [Atrial fibrillation as endpoint in studies of arterial hypertension].
Jung J
Dtsch Med Wochenschr; 2003 Nov; 128(47):2493-6. PubMed ID: 14628258
[No Abstract] [Full Text] [Related]
17. A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
Galzerano D; Di Michele S; Paolisso G; Tuccillo B; Lama D; Carbotta S; Cittadini A; Tedesco MA; Gaudio C
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):496-503. PubMed ID: 22546623
[TBL] [Abstract][Full Text] [Related]
18. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Aksnes TA; Flaa A; Strand A; Kjeldsen SE
J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
[TBL] [Abstract][Full Text] [Related]
19. [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients].
Belluzzi F; Sernesi L; Centola M; Perlini S
Recenti Prog Med; 2009 Nov; 100(11):508-11. PubMed ID: 20066882
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
